Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WuXi AppTec | Shanghai | Salute | Ricerca medica e biotecnologica | 137,46 Mrd CN¥ | 16x | -2,48 | 50,22 CN¥ | 4,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 24,5% Rialzo | Fai l’upgrade a Pro+ | |
Hangzhou Tigermed Consulting | Shenzhen | Salute | Ricerca medica e biotecnologica | 55,12 Mrd CN¥ | 49,2x | -0,92 | 64 CN¥ | 7,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7% Rialzo | Fai l’upgrade a Pro+ | |
Pharmaron Beijing | Shenzhen | Salute | Ricerca medica e biotecnologica | 48,91 Mrd CN¥ | 25,2x | 1,07 | 27,51 CN¥ | 7,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -2,3% Ribasso | Fai l’upgrade a Pro+ | |
Shanghai Allist Pharmaceuticals Co | Shanghai | Salute | Ricerca medica e biotecnologica | 22,76 Mrd CN¥ | 19,4x | 0,08 | 54,88 CN¥ | 8,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BGI Genomics | Shenzhen | Salute | Ricerca medica e biotecnologica | 17,57 Mrd CN¥ | 311,2x | -3,71 | 46,06 CN¥ | 3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Dizal Jiangsu Pharmaceutical | Shanghai | Salute | Ricerca medica e biotecnologica | 17,29 Mrd CN¥ | -15,5x | 8 | 44 CN¥ | 5,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 29,8% Rialzo | Fai l’upgrade a Pro+ | |
Sinocelltech Group | Shanghai | Salute | Ricerca medica e biotecnologica | 16,15 Mrd CN¥ | -122,4x | -1,89 | 38,10 CN¥ | 5,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
RemeGen | Shanghai | Salute | Ricerca medica e biotecnologica | 12,81 Mrd CN¥ | -3,3x | 0,26 | 31,22 CN¥ | 6,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -4,4% Ribasso | Fai l’upgrade a Pro+ | |
Beigene | Shanghai | Salute | Ricerca medica e biotecnologica | 12,73 Mrd CN¥ | -3,4x | -0,69 | 180,21 CN¥ | 5,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,7% Rialzo | Fai l’upgrade a Pro+ | |
Joinn Laboratories China | Shanghai | Salute | Ricerca medica e biotecnologica | 12,72 Mrd CN¥ | 90,6x | -1,03 | 16,94 CN¥ | 5,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -6,5% Ribasso | Fai l’upgrade a Pro+ | |
InnoCare Pharma | Shanghai | Salute | Ricerca medica e biotecnologica | 12,28 Mrd CN¥ | -21x | -1,11 | 13,97 CN¥ | 7,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Mabwell Shanghai Bioscience | Shanghai | Salute | Ricerca medica e biotecnologica | 9,39 Mrd CN¥ | -10,1x | 0,71 | 24,90 CN¥ | 6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bio-Thera Solutions | Shanghai | Salute | Ricerca medica e biotecnologica | 9,03 Mrd CN¥ | -22,1x | -0,77 | 23,40 CN¥ | 7,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 42,2% Rialzo | Fai l’upgrade a Pro+ | |
Sino Biological | Shenzhen | Salute | Ricerca medica e biotecnologica | 8,35 Mrd CN¥ | 36,5x | -2,18 | 69,54 CN¥ | 5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,7% Rialzo | Fai l’upgrade a Pro+ | |
InventisBio | Shanghai | Salute | Ricerca medica e biotecnologica | 5,51 Mrd CN¥ | -12,9x | -0,71 | 10,08 CN¥ | 5,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
GemPharmatech | Shanghai | Salute | Ricerca medica e biotecnologica | 4,92 Mrd CN¥ | 28,7x | 12,57 CN¥ | 4,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 39,1% Rialzo | Fai l’upgrade a Pro+ | ||
Beijing Kawin Technology Shareholding Co | Shanghai | Salute | Ricerca medica e biotecnologica | 4,69 Mrd CN¥ | 27,8x | 0,82 | 28,65 CN¥ | 2,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,9% Rialzo | Fai l’upgrade a Pro+ | |
R G PharmaStudies | Shenzhen | Salute | Ricerca medica e biotecnologica | 4,57 Mrd CN¥ | 23x | 2,03 | 49,83 CN¥ | 4,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,6% Rialzo | Fai l’upgrade a Pro+ | |
HitGen | Shanghai | Salute | Ricerca medica e biotecnologica | 4,45 Mrd CN¥ | 70,4x | 1,37 | 11,60 CN¥ | 4,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 6% Rialzo | Fai l’upgrade a Pro+ | |
Hangzhou BioSincerity PharmaTech | Shenzhen | Salute | Ricerca medica e biotecnologica | 4,44 Mrd CN¥ | 18,1x | 0,6 | 42,77 CN¥ | 4,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Beijing Sun Novo Pharmaceutical Research | Shanghai | Salute | Ricerca medica e biotecnologica | 4,36 Mrd CN¥ | 22,6x | 1,32 | 41,66 CN¥ | 6,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Shanghai Medicilon | Shanghai | Salute | Ricerca medica e biotecnologica | 4,26 Mrd CN¥ | -12x | 0,1 | 34,95 CN¥ | 9,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Shanghai Aladdin Biochemical Technology Co | Shanghai | Salute | Ricerca medica e biotecnologica | 3,63 Mrd CN¥ | 24,1x | 0,57 | 13,06 CN¥ | 4,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 12,4% Rialzo | Fai l’upgrade a Pro+ | |
Jiangsu Asieris Pharmaceuticals | Shanghai | Salute | Ricerca medica e biotecnologica | 3,41 Mrd CN¥ | -7,4x | 0,55 | 6,30 CN¥ | 3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Guangzhou Boji Medical & Biotech | Shenzhen | Salute | Ricerca medica e biotecnologica | 3,33 Mrd CN¥ | 89,6x | 4,7 | 8,78 CN¥ | 2,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 37,5% Rialzo | Fai l’upgrade a Pro+ | |
PharmaResources Shanghai | Shenzhen | Salute | Ricerca medica e biotecnologica | 3,27 Mrd CN¥ | 165,7x | -2,05 | 24,46 CN¥ | 3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hinova Pharmaceuticals | Shanghai | Salute | Ricerca medica e biotecnologica | 3,26 Mrd CN¥ | -10,7x | -0,5 | 34,60 CN¥ | 5,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ChemPartner PharmaTech | Shenzhen | Salute | Ricerca medica e biotecnologica | 3,12 Mrd CN¥ | -3,1x | 0,04 | 6,26 CN¥ | 2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Qingdao Vland Biotech | Shanghai | Salute | Ricerca medica e biotecnologica | 3,06 Mrd CN¥ | 35,2x | 1,06 | 11,90 CN¥ | 4,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Anhui Wanbang Pharmaceutical | Shenzhen | Salute | Ricerca medica e biotecnologica | 2,70 Mrd CN¥ | 20,2x | -1,01 | 41,78 CN¥ | 3,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |